MedTrace Logo

A Study of Circulating Immune Cell Activity Changes in Blood of Colorectal Cancer Patients

NCT02869269 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 67

Last updated 2018-01-29

No results posted yet for this study

Summary

Previous studies have shown that colorectal cancer patients' prognosis and overall survival was related with immune cell expression in patients' tissue. However, the circulating immune cell activity changes in patients' blood has few studies. The purpose of this study is to analyze the variation of circulating immune cell activity in colorectal patients' blood which is classed as clinical staging.

Conditions

Interventions

DEVICE

Early stage

patients who classed as clinical stage 1 and 2

DEVICE

Late stage

patients who classed as clinical stage 3 and 4

Sponsors & Collaborators

  • Konkuk University Medical Center

    lead OTHER

Principal Investigators

  • Seong-Hyop Kim, M.D,Ph.D · Konkuk University Medical Center

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-10-31
Primary Completion
2016-10-31
Completion
2016-10-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02869269 on ClinicalTrials.gov